11:15 AM EST - XORTX Therapeutics Inc. : Announces that it has received TSX Venture Exchange approval to amend the terms of the balance of outstanding common share purchase warrants that were issued on October 15, 2021. XORTX Therapeutics Inc.
shares V.XRTX are trading unchanged at $3.35.
